Effects of Saccharomyces Boulardii capsules in pediatric Inflammatory bowel disease
Phase 3
- Conditions
- Inflammatory bowel disease.
- Registration Number
- IRCT20120415009475N5
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Children the age of 1-16
Children with IBD
Exclusion Criteria
primary and secondary immunodeficiency
allergy to drug
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain. Timepoint: In this study we checked the effects of Saccharomyces Boulardii capsules in the beginning of the study and two months later. Method of measurement: by interview and completing Visual Analogue Scale by patients.;Quality of life. Timepoint: In this study we checked the effects of Saccharomyces Boulardii capsules in the beginning of the study and two months later. Method of measurement: By interview and completing IMPACT III questionnaire.
- Secondary Outcome Measures
Name Time Method